Lorati Company Limited has unveiled NanoClay Paste, a groundbreaking natural treatment designed to address chronic wounds and skin infections without the use of preservatives, organic compounds, or antibiotics. This innovation is particularly significant for individuals with diabetes, bacterial infections, or mobility issues, providing a safer and effective healing solution.
The paste, formulated with nano-grade montmorillonite and beidellite, has demonstrated rapid healing capabilities, with small diabetic wounds healing in as little as seven days and larger wounds within a month. This advancement could significantly reduce the risk of amputation among diabetic patients. Additionally, NanoClay Paste accelerates the recovery from bedsores and pressure ulcers, common among the elderly and bedridden patients, by promoting tissue regeneration.
Beyond wound care, the product offers relief from cellulitis and athlete's foot without the need for antibiotics or synthetic antifungal agents, and it soothes and heals burns of various degrees. Mr. David Lo, CEO of Lorati, emphasized the product's role in the company's mission to provide natural, non-invasive healing solutions, marking a significant step forward in wound care for patients at risk of infection or long-term complications.
With the launch of NanoClay Paste, Lorati continues to lead in the development of nano-grade mineral medicine, offering a promising alternative for individuals seeking effective and natural treatment options for chronic wounds and skin infections.
